Retraction notice to "Aberrant methylation of Reprimo in lung cancer" [Lung Cancer 47 (2005) 309-314];Aberrant methylation of Reprimo in lung cancer

Lung Cancer

Volumn 47, Issue 3, 2005, Pages 309-314

  Suzuki, Makoto ^a,b   Shigematsu, Hisayuki ^a   Takahashi, Takao ^a   Shivapurkar, Narayan ^a   Sathyanarayana, Ubaradka G ^a   Iizasa, Toshihiko ^b   Fujisawa, Takehiko ^b   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

G2 cell cycle; Lung cancer; Methylation; p53; Reprimo

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GLYCOSYLATED PROTEIN; PROTEIN P53; PROTEIN REPRIMO; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMETHYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; LYMPHOCYTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 13844257155     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.05.004     Document Type: Erratum

References (19)

1. P.A. Jones, and S.B. Baylin The fundamental role of epigenetic events in cancer Nat Rev Genet 3 2002 415 428
2. M. Esteller, P.G. Corn, S.B. Baylin, and J.G. Herman A gene hypermethylation profile of human cancer Cancer Res 61 2001 3225 3229
3. M. Suzuki, N. Sunaga, D.S. Shames, S. Toyooka, A.F. Gazdar, and J.D. Minna RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells Cancer Res 64 2004 3137 3143
4. S. Toyooka, K.O. Toyooka, R. Maruyama, A.K. Virmani, L. Girard, and K. Miyajima DNA methylation profiles of lung tumors Mol Cancer Ther 1 2001 61 67
5. S. Zochbauer-Muller, J.D. Minna, and A.F. Gazdar Aberrant DNA methylation in lung cancer: biological and clinical implications Oncologist 7 2002 451 457
6. R. Ohki, J. Nemoto, H. Murasawa, E. Oda, J. Inazawa, and N. Tanaka Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase J Biol Chem 275 2000 22627 22630
7. N. Sato, N. Fukushima, A. Maitra, H. Matsubayashi, C.J. Yeo, and J.L. Cameron Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays Cancer Res 63 2003 3735 3742
8. T. Otsuka, T. Kohno, M. Mori, M. Noguchi, S. Hirohashi, and J. Yokota Deletion mapping of chromosome 2 in human lung carcinoma Genes Chromosomes Cancer 16 1996 113 119
9. R.M. Phelps, B.E. Johnson, D.C. Ihde, A.F. Gazdar, D.P. Carbone, and P.R. McClintock NCI-Navy Medical Oncology Branch cell line data base J Cell Biochem Suppl 24 1996 32 91
10. S. Toyooka, Y. Fukuyama, I.I. Wistuba, M.S. Tockman, J.D. Minna, and A.F. Gazdar Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures Clin Cancer Res 8 2002 2292 2297
11. B.G. Herrmann, and A.M. Frischauf Isolation of genomic DNA Methods Enzymol 152 1987 180 183
12. J.G. Herman, J.R. Graff, S. Myohanen, B.D. Nelkin, and S.B. Baylin Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93 1996 9821 9826
13. V.A. Smits, and R.H. Medema Checking out the G2/M transition Biochim Biophys Acta 1519 2001 1 12
14. G.K. Dasika, S.C. Lin, S. Zhao, P. Sung, A. Tomkinson, and E.Y. Lee DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis Oncogene 18 1999 7883 7899
15. H. Suzuki, F. Itoh, M. Toyota, T. Kikuchi, H. Kakiuchi, and K. Imai Inactivation of the 14-3-3sigma gene is associated with 5′ CpG island hypermethylation in human cancers Cancer Res 60 2000 4353 4357
16. U.G. Sathyanarayana, M. Suzuki, S. Toyooka, A. Padar, K.O. Toyooka, and A.L. Zern Establishment and validation of quantitative real-time PCR assay for aberrant methylation of 14-3-3σ gene in breast and lung carcinoma Cancer genom proteom 1 2004 1 8
17. Z. Zhang, J. Li, L.E. Lantry, Y. Wang, R.W. Wiseman, and R.A. Lubet p53 transgenic mice are highly susceptible to 12-dimethylhydrazine-induced uterine sarcomas Cancer Res 62 2002 3024 3029
18. M.S. Greenblatt, W.P. Bennett, M. Hollstein, and C.C. Harris Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
19. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70